July 24, 2019 | City of Hope
An study conducted by Michael Caligiuri, M.D., and Jianhua Yu, Ph.D., unveiled why anti-PD-L1 monoclonal antibodies (mAb) are still effective in fighting tumors that lack PD-L1 receptors on their cells.
City of Hope scientist receives $9.28M for CAR T trial for metastatic breast cancer
August 15, 2019 | Letisia Marquez
Saul Priceman, Ph.D., and his research team have received a $9.28 million award from the California Institute for Regenerative Medicine to support a CAR T cell phase 1 clinical trial for the treatment of women with HER2-positive breast cancer that has spread to the brain.
Researcher Awarded $3M Grant to Study Genomics of Breast Cancer in Latinas
August 14, 2019 | Jenny Peters
City of Hope researcher Susan Neuhausen, Ph.D., is studying genomic breast cancer risk among Latinas. The research is vital, as Latinas are underrepresented in studies of breast cancer and genetic risk assessment.
From Oranges, a Powerful Potential Cancer Fighter
June 13, 2019 | Wayne Lewis
Sharad Singhal, Ph.D., research professor in the Department of Medical Oncology and Therapeutics Research, leads investigations focusing on a small molecule that is abundant in the pith of citrus fruit.
Researchers detail new findings at 2019 AACR meeting
March 28, 2019 | Zen Vuong
City of Hope will showcase ongoing studies and data on chimeric antigen receptor (CAR) T cell therapy, immunotherapy against solid tumors and more at the American Association for Cancer Research annual meeting from March 29 through April 3 in Atlanta.